Discovery - University of Dundee - Online Publications

Library & Learning Centre

Gillian Smith

1 - 76 out of 76Page size: 100
Sort by: Publication year
  1. Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity

    Deeni, Y. Y., Ibbotson, S. H., Woods, J. A., Wolf, C. R. & Smith, G. 23 Sep 2013 In : PLoS ONE. 8, 9, e75494

    Research output: Contribution to journalArticle

  2. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet (PUVA) sensitivity

    Deeni, Y. Y., Ibbotson, S. H., Woods, J. A., Wolf, C. R. & Smith, G. 23 Sep 2013 In : PLoS ONE. 8, 9, e75494

    Research output: Contribution to journalArticle

  3. Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer

    Smith, G., Ng, M. T. H., Shepherd, L., Herrington, C. S., Gourley, C., Ferguson, M. & Wolf, C. R. 9 Oct 2012 In : British Journal of Cancer. 107, 8, p. 1327-1336 10 p.

    Research output: Contribution to journalArticle

  4. Characterization of a Human Keratinocyte HaCaT Cell Line Model to Study the Regulation of CYP2S1

    McNeilly, A. D., Woods, J. A., Ibbotson, S. H., Wolf, C. R. & Smith, G. Feb 2012 In : Drug Metabolism and Disposition. 40, 2, p. 283-289 7 p.

    Research output: Contribution to journalArticle

  5. Glutathione S-transferase genotype is associated with sensitivity to psoralen-ultraviolet A photochemotherapy

    Ibbotson, S. H., Dawe, R. S., Dinkova-Kostova, A. T., Weidlich, S., Farr, P. M., Ferguson, J., Wolf, C. R. & Smith, G. Feb 2012 In : British Journal of Dermatology. 166, 2, p. 380-388 9 p.

    Research output: Contribution to journalArticle

  6. Pyrosequencing-based methods reveal marked inter-individual differences in oncogene mutation burden in human colorectal tumours

    Weidlich, S., Walsh, K., Crowther, D., Burczynski, M. E., Feuerstein, G., Carey, F., Steele, R. J. C., Wolf, C. R., Miele, G. & Smith, G. 12 Jul 2011 In : British Journal of Cancer. 105, 2, p. 246-254 9 p.

    Research output: Contribution to journalArticle

  7. Glutathione S-transferase M1 (GSTM1) genotype but not GSTT1 or MC1R genotype influences erythemal sensitivity to narrow band (TL-01) UVB phototherapy

    Smith, G., Weidlich, S., Dawe, R. S. & Ibbotson, S. H. Apr 2011 In : Pharmacogenetics and Genomics. 21, 4, p. 217-224 8 p.

    Research output: Contribution to journalArticle

  8. Activating K-Ras mutations outwith "hotspot" codons in sporadic colorectal tumours: implications for personalised cancer medicine

    Smith, G., Bounds, R., Wolf, H., Pratt, N., Carey, F., Steele, R. & Wolf, C. Sep 2010 In : Journal of Pathology. 222, S1, p. S12-S12 1 p.

    Research output: Contribution to journalBook/Film/Article review

  9. Glutathione S-transferase M1 (GSTM1) genotype is associated with serum 8-MOP concentration and PUVA sensitivity

    Ibbotson, S. H., Dawe, R. S., Weidlich, S., Dinkova-Kostova, A. T., Farr, P. M., Ferguson, J., Wolf, C. R. & Smith, G. Apr 2010 In : British Journal of Dermatology. 162, 4, p. 941-941 1 p.

    Research output: Contribution to journalMeeting abstract

  10. Activating K-Ras mutations outwith 'hotspot' codons in sporadic colorectal tumours: implications for personalised cancer medicine

    Smith, G., Bounds, R., Wolf, H., Steele, R., Carey, F. & Wolf, R. 16 Feb 2010 In : British Journal of Cancer. 102, 4, p. 693-703 11 p.

    Research output: Contribution to journalArticle

  11. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk

    Northwood, E. L., Elliott, F., Forman, D., Barrett, J. H., Wilkie, M. J. V., Carey, F. A., Steele, R. J. C., Wolf, R., Bishop, T. & Smith, G. 2010 In : Pharmacogenetics and Genomics. 20, 5, p. 315-326 12 p.

    Research output: Contribution to journalArticle

  12. Genetic Variants in XRCC2: New Insights Into Colorectal Cancer Tumorigenesis

    Curtin, K., Lin, W-Y., George, R., Katory, M., Shorto, J., Cannon-Albright, L. A., Smith, G., Bishop, D. T., Cox, A., Camp, N. J. & Colorectal Canc Study Grp Sep 2009 In : Cancer Epidemiology, Biomarkers & Prevention. 18, 9, p. 2476-2484 9 p.

    Research output: Contribution to journalArticle

  13. Glutathione S-transferase M1 genotype is associated with erythemal sensitivity to narrowband ultraviolet B in patients with psoriasis

    Ibbotson, S. H., Weidlich, S., Ferguson, J., Wolf, R., Dawe, R. S. & Smith, G. Apr 2009 In : British Journal of Dermatology. 160, 4, p. 928-928 1 p.

    Research output: Contribution to journalArticle

  14. Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy

    Wilkie, M. J. V., Smith, G., Day, R., Matthews, K., Smith, D., Blackwood, D., Reid, I. C. & Wolf, R. 2009 In : Pharmacogenomics Journal. 9, 1, p. 61-70 10 p.

    Research output: Contribution to journalArticle

  15. Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer

    Lightfoot, T. J., Barrett, J. H., Bishop, T., Northwood, E. L., Smith, G., Wilkie, M. J. V., Steele, R. J. C., Carey, F. A., Key, T. J., Wolf, R. & Forman, D. Sep 2008 In : Cancer Epidemiology, Biomarkers & Prevention. 17, 9, p. 2421-2430 10 p.

    Research output: Contribution to journalArticle

  16. DUSP6/MKP-3 expression and K-ras mutation in colorectal cancer

    Conlin, A., Smith, G., Steele, R. J. C. & Wolf, C. R. Mar 2008 In : Gut. 57, Supplement 1, p. A134-A134 1 p.350

    Research output: Contribution to journalBook/Film/Article review

  17. Melanocortin 1 receptor (MC1R) genotype influences erythemal sensitivity to psoralen-ultraviolet A photochemotherapy

    Smith, G., Wilkie, M. J. V., Deeni, Y. Y., Farr, P. M., Ferguson, J., Wolf, C. R. & Ibbotson, S. H. Dec 2007 In : British Journal of Dermatology. 157, 6, p. 1230-4 5 p.

    Research output: Contribution to journalArticle

  18. A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression

    Wilkie, M. J. V., Smith, D., Reid, I. C., Day, R. K., Matthews, K., Wolf, R., Blackwood, D. & Smith, G. Mar 2007 In : Pharmacogenetics and Genomics. 17, 3, p. 207-215 9 p.

    Research output: Contribution to journalArticle

  19. Can dietary furanocoumarin ingestion enhance the erythemal response during high-dose UVA1 therapy?

    Beattie, P. E., Wilkie, M. J. V., Smith, G., Ferguson, J. & Ibbotson, S. Jan 2007 In : Journal of the American Academy of Dermatology. 56, 1, p. 84-87 4 p.

    Research output: Contribution to journalArticle

  20. Genetic factors associated with the aetiology and treatment of colorectal cancer

    Wolf, C. R., Steele, R. J. C., Carey, F. A., Pratt, N. D., Bishop, D. T., Barrett, J. H., Forman, D. & Smith, G. 1 Sep 2006 In : Toxicology. 226, 1, p. 14-14 1 p.

    Research output: Contribution to journalMeeting abstract

  21. Inter- and intrasubject variation in cytoprotective gene expression in patients with psoriasis

    Smith, G., Hearn, R., Wolf, C. R., Ferguson, J. & Ibbotson, S. H. Jul 2006 In : British Journal of Dermatology. 155, 1, p. 254-254 1 p.P26

    Research output: Contribution to journalMeeting abstract

  22. Melanocortin 1 receptor genotype influences erythemal sensitivity and treatment response in patients undergoing psoralen plus ultraviolet A treatment

    Smith, G., Wilkie, M. J. V., Deeni, Y. Y., Ferguson, J., Wolf, C. R. & Ibbotson, S. H. Jul 2006 In : British Journal of Dermatology. 155, 1, p. 240-240 1 p.O15

    Research output: Contribution to journalMeeting abstract

  23. Chromosomal changes in colorectal adenomas: relationship to gene mutations and potential for clinical utility

    Leslie, A., Stewart, A., Baty, D. U., Mechan, D., McGreavey, L., Smith, G., Wolf, C. R., Sales, M., Pratt, N. R., Steele, R. J. C. & Carey, F. A. Feb 2006 In : Genes, Chromosomes and Cancer. 45, 2, p. 126-135 10 p.

    Research output: Contribution to journalArticle

  24. Identification of CYP2S1 ligands

    Dickmann, L. J., Deeni, Y., Smith, G. & Wolf, C. R. 2006 In : Drug Metabolism Reviews. 38, Suppl., p. 56-56 1 p.

    Research output: Contribution to journalMeeting abstract

  25. Identification of CYP2S1 ligands

    Dickmann, L. J., Deeni, Y., Smith, G. & Wolf, C. R. 2006

    Research output: Contribution to conferenceAbstract

  26. Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo

    Smith, G., Ibbotson, S. H., Comrie, M. M., Dawe, R. S., Bryden, A., Ferguson, J. & Wolf, C. R. 2006 In : British Journal of Dermatology. 155, 2, p. 275-81 7 p.

    Research output: Contribution to journalArticle

  27. Mutation and tissue microarray analysis of tumour suppressor genes and cell cycle-related proteins in colorectal cancer

    Robertson, K. E., Conlin, A., Miller, J., Smith, G., Steele, R. J. C., Wolf, C. R., Levison, D. A. & Carey, F. A. 2005 In : Journal of Pathology. 207, Suppl. 1, p. 43-43 1 p.

    Research output: Contribution to journalMeeting abstract

  28. Mutation and tissue microarray analysis of tumour suppressor genes and cell cycle-related proteins in colorectal cancer

    Robertson, K. E., Conlin, A., Miller, J., Smith, G., Steele, R. J. C., Wolf, C. R., Levison, D. A. & Carey, F. A. 2005

    Research output: Contribution to conferenceAbstract

  29. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPAR[delta] and PPAR[gamma] act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma

    McGreavey, L. E., Turner, F., Smith, G., Boylan, K., Bishop, D. T., Forman, D., Wolf, C. R. & Barrett, J. H. 2005 In : Pharmacogenetics and Genomics. 15, 10, p. 713-721 9 p.

    Research output: Contribution to journalArticle

  30. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma

    Conlin, A., Smith, G., Carey, F. A., Wolf, C. R. & Steele, R. J. C. 2005 In : Gut. 54, 9, p. 1283-1286 4 p.

    Research output: Contribution to journalArticle

  31. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer

    Turner, F., Smith, G., Sachse, C., Lightfoot, T., Garner, R. C., Wolf, C. R., Forman, D., Bishop, D. T., Barrett, J. H. & Colorectal Cancer Study Group 1 Nov 2004 In : International Journal of Cancer. 112, 2, p. 259-264 6 p.

    Research output: Contribution to journalArticle

  32. Regulation of cytochrome P450 CYP2S1 in human skin by UVR and topical drugs used to treat psoriasis

    Smith, G., Deeni, Y. Y., Dawe, R. S., Evans, A. T., Ferguson, J., Wolf, C. R. & Ibbotson, S. H. Aug 2004 In : Drug Metabolism Reviews. 36, Supplement 1, p. 181-181 1 p.363

    Research output: Contribution to journalMeeting abstract

  33. No association of polymorphisms in CYP17, CYP19, and HSD17-B1 with plasma estradiol concentrations in 1,090 British women

    Travis, R. C., Churchman, M., Edwards, S. A., Smith, G., Verkasalo, P. K., Wolf, C. R., Wolf, H. & Key, T. J. 2004 In : Cancer Epidemiology, Biomarkers & Prevention. 13, 12, p. 2282-4 3 p.

    Research output: Contribution to journalArticle

  34. Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure

    Jetter, A., Kinzig-Schippers, M., Illauer, M., Hermann, R., Erb, K., Borlak, J., Wolf, H., Smith, G., Cascorbi, I., Sorgel, F. & Fuhr, U. 2004 In : European Journal of Clinical Pharmacology. 60, 1, p. 17-21 5 p.

    Research output: Contribution to journalArticle

  35. Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas

    Leslie, A., Pratt, N. R., Gillespie, K., Sales, M., Kernohan, N. M., Smith, G., Wolf, C. R., Carey, F. A. & Steele, R. J. C. Aug 2003 In : Cancer Research. 63, 15, p. 4656-4661 6 p.

    Research output: Contribution to journalArticle

  36. Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation

    Smith, G., Dawe, R. S., Clark, C., Evans, A. T., Comrie, M. M., Wolf, C. R., Ferguson, J. & Ibbotson, S. H. Aug 2003 In : Journal of Investigative Dermatology. 121, 2, p. 390-398 9 p.

    Research output: Contribution to journalArticle

  37. Cytochrome P450 CYP2S1 expression in human skin: individuality in regulation by therapeutic agents for psoriasis and other skin diseases

    Smith, G., Deeni, Y. Y., Dawe, R. S., Comrie, M. M., Wolf, C. R., Ferguson, J. & Ibbotson, S. H. Apr 2003 In : British Journal of Dermatology. 148, 4, p. 853-853 1 p.O16

    Research output: Contribution to journalMeeting abstract

  38. Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases

    Smith, G., Wolf, C. R., Deeni, Y. Y., Dawe, R. S., Evans, A. T., Comrie, M. M., Ferguson, J. & Ibbotson, S. H. 2003 In : Lancet. 361, 9366, p. 1336-1343 8 p.

    Research output: Contribution to journalArticle

  39. Investigation of interaction between N-acetyltransferase 2 and heterocyclic amines as potential risk factors for colorectal cancer

    Barrett, J. H., Smith, G., Waxman, R., Gooderham, N., Lightfoot, T., Garner, R. C., Augustsson, K., Wolf, C. R., Bishop, D. T. & Forman, D. 2003 In : Carcinogenesis. 24, 2, p. 275-282 8 p.

    Research output: Contribution to journalArticle

  40. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism

    Sachse, C., Bhambra, U., Smith, G., Lightfoot, T. J., Barrett, J. H., Scollay, J., Garner, R. C., Boobis, A. R., Wolf, C. R., Gooderham, N. J. & Colorectal Cancer Study Group 2003 In : British Journal of Clinical Pharmacology. 55, 1, p. 68-76 9 p.

    Research output: Contribution to journalArticle

  41. Topical coal tar and all-trans retinoic acid modulate drug metabolising gene expression in human skin in vivo

    Ibbotson, S. H., Smith, G., Sawe, R. S., Comrie, M. M., Bryden, A., Wolf, C. E. & Ferguson, J. 2003 In : British Journal of Dermatology. 148, 4, p. 861-861 1 p.P15

    Research output: Contribution to journalMeeting abstract

  42. Topical coal tar and all-trans retinoic acid modulate drug metabolising gene expression in human skin in vivo

    Ibbotson, S. H., Smith, G., Sawe, R. S., Comrie, M. M., Bryden, A., Wolf, C. E. & Ferguson, J. 2003

    Research output: Contribution to conferencePoster

  43. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer

    Sachse, C., Smith, G., Wilkie, M. J. V., Barrett, J. H., Waxman, R., Sullivan, F., Forman, D., Bishop, D. T., Wolf, C. R. & Colorectal Cancer Study Group Nov 2002 In : Carcinogenesis. 23, 11, p. 1839-49 11 p.

    Research output: Contribution to journalArticle

  44. Expression and regulation of cytoprotective genes by ultraviolet radiation in skin of patients with psoriasis

    Smith, G., Dawe, R. S., Evans, A. T., Comrie, M. M., Ferguson, J., Wolf, C. R. & Ibbotson, S. H. Sep 2002 In : Journal of Investigative Dermatology. 119, 3, p. 740-740 1 p.166

    Research output: Contribution to journalMeeting abstract

  45. Chromosomal abnormality and gene mutation in sporadic colorectal cancer

    Leslie, A., Smith, G., Pratt, N. R., Carey, F. A., Wolf, C. R. & Steele, R. J. C. 2002 In : British Journal of Surgery. 89, 5, p. 663-664 2 p.

    Research output: Contribution to journalMeeting abstract

  46. Factors influencing the cellular accumulation of SN-38 and camptothecin

    Cummings, J., Boyd, G., Macpherson, J. S., Wolf, H., Smith, G., Smyth, J. F. & Jodrell, D. I. 2002 In : Cancer Chemotherapy and Pharmacology. 49, 3, p. 194-200 7 p.

    Research output: Contribution to journalArticle

  47. Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer

    Smith, G., Carey, F. A., Beattie, J., Wilkie, M. J. V., Lightfoot, T. J., Coxhead, J., Garner, R. C., Steele, R. J. C. & Wolf, C. R. 2002 In : Proceedings of the National Academy of Sciences of the United States of America. 99, 14, p. 9433-9438 6 p.

    Research output: Contribution to journalArticle

  48. Relation of mismatch repair protein status with mutational and chromosomal abnormalities in colorectal cancer

    Allen, D., Smith, G., Steele, R. J. C., Wolf, C. R. & Carey, F. A. 2002 In : Journal of Pathology. 198, 1, p. 34A-34A 1 p.

    Research output: Contribution to journalMeeting abstract

  49. The adenoma carcinoma sequence in colorectal cancer - evidence for separate pathways based on p53 and K-ras mutation and chromosomal analysis

    Leslie, A., Smith, G., Kernohan, N. M., Pratt, N., Steele, R. J. C., Wolf, C. R. & Carey, F. A. 2002 In : Journal of Pathology. 198, 1, p. 4A-4A 1 p.

    Research output: Contribution to journalMeeting abstract

  50. Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR

    Finnström, N., Bjelfman, C., Söderström, T. G., Smith, G., Egevad, L., Norlén, B. J., Wolf, C. R. & Rane, A. 2001 In : European Journal of Clinical Investigation. 31, 10, p. 880-886 7 p.

    Research output: Contribution to journalArticle

  51. Investigation of interaction between N-acetyltransferase 2 (NAT2) phenotype and heterocyclic amines as potential risk factors for colorectal cancer

    Barrett, J. H., Bishop, D. T., Waxman, R., Forman, D., Lightfoot, T., Garner, C., Smith, G. & Wolf, R. 2001 In : American Journal of Human Genetics. 69, 4 Suppl., p. 263-263 1 p.469

    Research output: Contribution to journalMeeting abstract

  52. Investigation of interaction between N-acetyltransferase 2 (NAT2) phenotype and heterocyclic amines as potential risk factors for colorectal cancer

    Barrett, J. H., Bishop, D. T., Waxman, R., Forman, D., Lightfoot, T., Garner, C., Smith, G. & Wolf, R. 2001

    Research output: Contribution to conferencePaper

  53. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6

    Ellis, S. W., Hayhurst, G. P., Lightfoot, T., Smith, G., Harlow, J., Rowland-Yeo, K., Larsson, C., Mahling, J., Lim, C. K., Wolf, C. R., Blackburn, M. G., Lennard, M. S. & Tucker, G. T. 2000 In : Biochemical Journal. 345 , 3, p. 565-571 7 p.

    Research output: Contribution to journalArticle

  54. Pharmacogenetics

    Wolf, C. R., Smith, G. & Smith, R. L. 2000 In : British Medical Journal. 320, 7240, p. 987-90 4 p.

    Research output: Contribution to journalArticle

  55. Adaptive responses to environmental chemicals

    Wolf, C. R., Smith, G., Smith, A. G., Brown, K. & Henderson, C. J. 1999 Cellular responses to stress. Downes, C. P., Wolf, C. R. & Lane, D. P. (eds.). London: Portland Press Ltd, p. 129-139 11 p. (Biochemical Society symposia; 64).

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  56. Cytochrome P450 CYP2D6

    Wolf, C. R. & Smith, G. 1999 In : IARC Scientific Publications. 148, p. 209-29 21 p.

    Research output: Contribution to journalArticle

  57. Pharmacogenetics

    Wolf, C. R. & Smith, G. 1999 In : British Medical Bulletin. 55, 2, p. 366-86 21 p.

    Research output: Contribution to journalArticle

  58. Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity

    Smith, G., Modi, S., Pillai, I., Lian, L-Y., Sutcliffe, M. J., Pritchard, M. P., Friedberg, T., Roberts, G. C. K. & Wolf, C. R. 1998 In : Biochemical Journal. 331 , 3, p. 783-792 10 p.

    Research output: Contribution to journalArticle

  59. Molecular genetics of the human cytochrome P450 monooxygenase superfamily

    Smith, G., Stubbins, M. J., Harries, L. W. & Wolf, C. R. 1998 In : Xenobiotica. 28, 12, p. 1129-1165 37 p.

    Research output: Contribution to journalArticle

  60. Genetic structural and functional analysis of cytochrome P450s in the CYP2D gene family

    Wolf, C. R., Modi, S., Lian, L. Y., Paine, M., Smith, G. & Roberts, G. C. K. 31 Jul 1997 In : FASEB Journal. 11, 9, p. A773-A773 1 p.P25

    Research output: Contribution to journalMeeting abstract

  61. Active site models of human cytochrome P450s based on NMR relaxation measurements

    Modi, S., Paine, M. J., Oliver, C. F., Smith, G., Sutcliffe, M. J., Gilham, D. E., Shaw, A. N. J., Lian, L. Y., Primrose, W. U., Wolf, C. R. & Roberts, G. C. K. 1997 In : FASEB Journal. 11, 9, p. A771-A771 1 p.

    Research output: Contribution to journalMeeting abstract

  62. Active-site topologies of human CYP2D6 and its aspartate-301 → glutamate, asparagine, and glycine mutants

    Mackman, R., Tschirret-Guth, R. A., Smith, G., Hayhurst, G. P., Ellis, S. W., Lennard, M. S., Tucker, G. T., Wolf, C. R. & Ortiz de Montellano, P. R. 1996 In : Archives of Biochemistry and Biophysics. 331, 1, p. 134-140 7 p.

    Research output: Contribution to journalArticle

  63. Genetic analysis of the human cytochrome P450 CYP2C9 locus

    Stubbins, M. J., Harries, L. W., Smith, G., Tarbit, M. H. & Wolf, C. R. 1996 In : Pharmacogenetics. 6, 5, p. 429-39 11 p.

    Research output: Contribution to journalArticle

  64. Characterization of anti-LKM-antibody targets in patients with autoimmune hepatitis typ2 and hepatitis-C

    Thalhammer, T., Smith, G., Wolf, H., Wolf, R., Boltznitulescu, G., Dopplinger, C. & Penner, E. 1995 In : FASEB Journal. 9, 3, p. A146 1 p.851

    Research output: Contribution to journalMeeting abstract

  65. Evidence that aspartic acid 301 is a critical substrate-contact residue in the active site of cytochrome P450 2D6

    Ellis, S. W., Hayhurst, G. P., Smith, G., Lightfoot, T., Wong, M. M. S., Simula, A. P., Ackland, M. J., Sternberg, M. J. E., Lennard, M. S., Tucker, G. T. & Wolf, C. R. 1995 In : Journal of Biological Chemistry. 270, 49, p. 29055-29058 4 p.

    Research output: Contribution to journalComment/debate

  66. Metabolic polymorphisms and cancer susceptibility

    Smith, G., Stanley, L. A., Sim, E., Strange, R. C. & Wolf, C. R. 1995 In : Cancer Surveys. 25, p. 27-65 39 p.

    Research output: Contribution to journalArticle

  67. Genetic polymorphisms in xenobiotic metabolism

    Smith, C. A. D., Smith, G. & Wolf, C. R. 1994 In : European Journal of Cancer. 30, 13, p. 1921-35 15 p.

    Research output: Contribution to journalArticle

  68. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression.

    Smith, G., Henderson, C. J., WHITE, R., Parker, M. G., Bars, R. G. & Wolf, C. R. 1 Feb 1993 In : Biochemical Journal. 289, 3, p. 807-813 7 p.

    Research output: Contribution to journalArticle

  69. Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis

    Smith, G. C. M., Wolf, C. R., Kenna, J. G., Harrison, D. J. & Tew, D. 1993 In : Lancet. 342, 8877, p. 963-4 2 p.

    Research output: Contribution to journalArticle

  70. Regulation of cytochrome P450 gene expression in human colon and breast tumour xenografts

    Smith, G., Harrison, D. J., East, N., Rae, F., Wolf, H. & Wolf, C. R. 1993 In : British Journal of Cancer. 68, 1, p. 57-63 7 p.

    Research output: Contribution to journalArticle

  71. Production of cytochrome P450 reductase yeast-rat hybrid proteins in Saccharomyces cerevisiae

    Bligh, H. F. J., Wolf, C. R., Smith, G. & Beggs, J. D. 2 Jan 1992 In : Gene. 110, 1, p. 33-9 7 p.

    Research output: Contribution to journalArticle

  72. Molecular genetics of the human cytochrome P450-dependent monooxygenases

    Wolf, C. R., Smith, C. A. D., Smith, G., Gough, A. C., Bryant, S., Spurr, N. K. & Harrison, D. J. 1992 In : The Tohoku Journal of Experimental Medicine. 168, 2, p. 73-81 9 p.

    Research output: Contribution to journalArticle

Find Researchers in Discovery

Library & Learning Centre

Contact | Accessibility | Policy